Overall, GLP-1 RAs appear to be more efficacious than DPP4 inhibitors in people with type 2 diabetes in terms of improving glycaemic control and reducing body weight (Gilbert and Pratley, 2020)
A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion
Adding semaglutide to retatrutide would duplicate GLP-1 receptor activation, which could increase side effects without proportionally increasing efficacy
Treating it with ongoing medication that effectively manages those drivers is rational medicine
At the drug level, Mounjaro accounts for 35.2% of total revenue, while Zepbound accounts for 20.8%
Retatrutide Research Context: Where It Fits in Metabolic Peptide Science To fully appreciate why researchers buy retatrutide for metabolic investigation, it helps to understand the broader landscape of GLP-1-based research